Asthma Control Test Guided Treatment in Chinese Subjects
The Effectiveness of Asthma Control Test Guided Treatment Compared With Usual Care in China Adult Asthma Patients
Sponsor: GlaxoSmithKline
Listed as NCT02868281, this PHASE4 trial focuses on Asthma and remains completed. Sponsored by GlaxoSmithKline, it has been updated 13 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Completed PHASE4
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 8 earlier versions
-
Oct 2019 — Sep 2020 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE4
-
Jul 2019 — Sep 2019 [monthly]
Recruiting PHASE4
-
May 2019 — Jul 2019 [monthly]
Recruiting PHASE4
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE4
-
Jul 2018 — Apr 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GlaxoSmithKline
- MacroStat
For direct contact, visit the study record on ClinicalTrials.gov .